| 1 |
transthyretin
(1827 times)
|
Biochemistry
(415 times)
|
FAP (329 times)
RBP (130 times)
CSF (73 times)
|
1984 Immunocytochemical studies on the localization of plasma and of cellular retinol-binding proteins and of transthyretin (prealbumin) in rat liver and kidney.
|
| 2 |
therapeutic range
(421 times)
|
Vascular Diseases
(98 times)
|
INR (169 times)
AF (120 times)
VKA (52 times)
|
2006 Worldwide management of oral anticoagulant therapy: the ISAM study.
|
| 3 |
time to recurrence
(207 times)
|
Neoplasms
(123 times)
|
OS (133 times)
HCC (60 times)
HR (36 times)
|
1993 Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.
|
| 4 |
time to relapse
(45 times)
|
Neoplasms
(24 times)
|
OS (18 times)
NSCLC (6 times)
AML (4 times)
|
1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
|
| 5 |
time to response
(29 times)
|
Neoplasms
(17 times)
|
DOR (12 times)
ORR (11 times)
PFS (9 times)
|
1981 Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.
|
| 6 |
wild-type transthyretin
(20 times)
|
Biochemistry
(4 times)
|
SSA (7 times)
FAP (3 times)
HFpEF (2 times)
|
1996 Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
|
| 7 |
time to tumor recurrence
(17 times)
|
Neoplasms
(9 times)
|
OS (8 times)
HR (6 times)
CI (4 times)
|
2008 Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
|
| 8 |
time to results
(15 times)
|
Microbiology
(7 times)
|
AST (2 times)
DST (2 times)
LOD (2 times)
|
2002 Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
|
| 9 |
time-in-therapeutic range
(12 times)
|
Vascular Diseases
(9 times)
|
AF (3 times)
INR (2 times)
ACR (1 time)
|
2003 Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.
|
| 10 |
tracer-to-tracee ratio
(12 times)
|
Physiology
(4 times)
|
EGP (2 times)
GC/MS (2 times)
IVGTT (2 times)
|
1997 Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: application to measurement of muscle protein synthesis.
|
| 11 |
thermotolerance ratio
(11 times)
|
Neoplasms
(6 times)
|
CHM (2 times)
PUR (2 times)
SUH (1 time)
|
1984 Heat sensitivity and thermotolerance in cells from five human melanoma xenografts.
|
| 12 |
transthyretin gene
(10 times)
|
Nervous System Diseases
(2 times)
|
AAO (1 time)
ATTR (1 time)
BCVA (1 time)
|
2009 Transthyretin gene (TTR) intron 1 elucidates crocodylian phylogenetic relationships.
|
| 13 |
type-token ratio
(9 times)
|
Speech-Language Pathology
(3 times)
|
MLUw (2 times)
BG (1 time)
BNT (1 time)
|
1981 Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia.
|
| 14 |
tear turnover rate
(8 times)
|
Ophthalmology
(6 times)
|
ADDE (2 times)
EDE (2 times)
bTTR (1 time)
|
2001 An improved fluorophotometric method for tear turnover assessment.
|
| 15 |
anti-transthyretin
(7 times)
|
Neurology
(4 times)
|
AAV (1 time)
AD (1 time)
bGH (1 time)
|
1993 Immunoassay for transthyretin variants associated with amyloid neuropathy.
|
| 16 |
target therapeutic range
(7 times)
|
Vascular Diseases
(3 times)
|
AF (2 times)
INR (2 times)
OAT (1 time)
|
2003 Acenocoumarol therapy in pediatric patients.
|
| 17 |
type transthyretin
(7 times)
|
Biochemistry
(2 times)
|
AgRP (1 time)
CAGE (1 time)
DEGs (1 time)
|
2008 Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
|
| 18 |
time to recovery
(6 times)
|
Cardiology
(1 time)
|
HD (2 times)
AUCs (1 time)
BFR (1 time)
|
1997 The prediction of length of major depressive episodes: results from an epidemiological sample of female twins.
|
| 19 |
time to resolution
(5 times)
|
Neoplasms
(4 times)
|
sTRAEs (2 times)
TTO (2 times)
AMC (1 time)
|
2014 Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.
|
| 20 |
RBP-transthyretin
(4 times)
|
Biochemistry
(3 times)
|
RBP (3 times)
Ito (1 time)
mAbs (1 time)
|
1991 Regulation of retinol uptake and esterification in MCF-7 and HepG2 cells by exogenous fatty acids.
|
| 21 |
Tabtoxin resistance protein
(4 times)
|
Molecular Biology
(2 times)
|
AcCoA (2 times)
GNAT (1 time)
HATs (1 time)
|
2001 Crystallization and preliminary X-ray crystallographic analysis of native and selenomethionyl recombinant tabtoxin-resistance protein complexed with acetyl-coenzyme A.
|
| 22 |
target range
(4 times)
|
Vascular Diseases
(2 times)
|
AF (2 times)
INR (2 times)
AC (1 time)
|
2000 Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.
|
| 23 |
time to disease recurrence
(4 times)
|
Neoplasms
(4 times)
|
OS (2 times)
EHC (1 time)
GBC (1 time)
|
2010 The prognostic value of tumor mitotic rate and other clinicopathologic factors in patients with locoregional recurrences of melanoma.
|
| 24 |
transition temperature ranges
(4 times)
|
Orthodontics
(3 times)
|
DSC (2 times)
Af (1 time)
Ms (1 time)
|
1980 A clinical trial of alignment of teeth using a 0.019 inch thermal nitinol wire with a transition temperature range between 31 degrees C. and 45 degrees C.
|
| 25 |
translation regulatory
(4 times)
|
Chemistry
(1 time)
|
RBPs (3 times)
DSRBPs (1 time)
NF90 (1 time)
|
2007 Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.
|
| 26 |
transporter transthyretin
(4 times)
|
Toxicology
(2 times)
|
AD (1 time)
BBB (1 time)
CPs (1 time)
|
2002 Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.
|
| 27 |
TBG, transthyretin
(3 times)
|
Neoplasms
(1 time)
|
TBG (2 times)
ACT (1 time)
AT (1 time)
|
1992 Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
|
| 28 |
tetrathionate reductase
(3 times)
|
Microbiology
(2 times)
|
TSO (2 times)
TSR (1 time)
|
1980 Thiosulfate Oxidation and Tetrathionate Reduction by Intact Cells of Marine Pseudomonad Strain 16B.
|
| 29 |
therapeutic International Normalized Ratio range
(3 times)
|
Vascular Diseases
(1 time)
|
ACTS (1 time)
AF (1 time)
RE-LY (1 time)
|
2010 Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
|
| 30 |
time-to-repeat
(3 times)
|
Endocrinology
(2 times)
|
CBG (1 time)
ICU (1 time)
IMC (1 time)
|
2017 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
|
| 31 |
transcriptional termination region
(3 times)
|
Clinical Laboratory Techniques
(1 time)
|
CGIs (1 time)
DME-like (1 time)
nc (1 time)
|
2008 Genetic heterogeneity of the dnaK gene locus including transcription terminator region (TTR) in Campylobacter lari.
|
| 32 |
transient thermoreflectance
(3 times)
|
Biomedical Engineering
(3 times)
|
FDTR (1 time)
|
2008 Pulse accumulation, radial heat conduction, and anisotropic thermal conductivity in pump-probe transient thermoreflectance.
|
| 33 |
transthyretin-related
(3 times)
|
Biochemistry
(1 time)
|
AC (1 time)
AL (1 time)
CI (1 time)
|
2005 Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation.
|
| 34 |
Trauma Triage Rule
(3 times)
|
Emergency Medicine
(3 times)
|
---
|
1992 Comparative performance of the Baxt Trauma Triage Rule.
|
| 35 |
true three-dimensional reconstruction
(3 times)
|
Diagnostic Imaging
(2 times)
|
ETTR (1 time)
TTCR (1 time)
|
1983 True Three-Dimensional Reconstruction (TTR) Application of Algorithm toward Full Utilization of Oblique Rays.
|
| 36 |
targeting transthyretin
(2 times)
|
Therapeutics
(1 time)
|
1,5-AmNS (1 time)
1,8-ANS (1 time)
siRNA (1 time)
|
2010 Identification of a novel ligand binding motif in the transthyretin channel.
|
| 37 |
tetrameric transthyretin
(2 times)
|
Chemistry
(1 time)
|
FAP (1 time)
SSA (1 time)
|
2005 Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
|
| 38 |
TH transport proteins, transthyretin
(2 times)
|
Toxicology
(1 time)
|
Cl-PFAESs (1 time)
PFASs (1 time)
PFOS (1 time)
|
2016 Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
|
| 39 |
thyroglossal tract remnant
(2 times)
|
Otolaryngology
(1 time)
|
---
|
2008 Thyroglossal duct cyst: personal experience and literature review.
|
| 40 |
thyroxin transport protein, transthyretin
(2 times)
|
Environmental Pollutants
(1 time)
|
---
|
2005 Hydroxylated polychlorinated biphenyls (OH-PCBs): recent advances in wildlife contamination study.
|
| 41 |
tibiotalar ratio
(2 times)
|
Orthopedics
(2 times)
|
---
|
2016 Talolisthesis in end stage ankle arthrosis.
|
| 42 |
tibiotarsal rotation
(2 times)
|
Veterinary Medicine
(2 times)
|
---
|
1998 Factors on farms in eastern Australia associated with the development of tibiotarsal rotation in ostrich chicks.
|
| 43 |
time from initial diagnosis to relapse
(2 times)
|
Transplantation
(1 time)
|
ALC-R (1 time)
DLBCL (1 time)
IPI-R (1 time)
|
2008 Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
|
| 44 |
time to overall recurrence
(2 times)
|
Neoplasms
(2 times)
|
OS (1 time)
TTLiR (1 time)
TTM (1 time)
|
2008 Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
|
| 45 |
time to re-treatment
(2 times)
|
Hematology
(1 time)
|
CLL (1 time)
IgVH (1 time)
PFS (1 time)
|
2008 Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
|
| 46 |
time to tumour response
(2 times)
|
Neoplasms
(1 time)
|
PFS (2 times)
CK (1 time)
CR (1 time)
|
2014 Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials.
|
| 47 |
time-to-readmission
(2 times)
|
General Surgery
(2 times)
|
---
|
2015 Time-to-readmission and Mortality After High-risk Surgery.
|
| 48 |
total thermal response
(2 times)
|
Neurology
(2 times)
|
DA (2 times)
GFAP (2 times)
CP (1 time)
|
1997 Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.
|
| 49 |
transthoracic resistance
(2 times)
|
Cardiology
(2 times)
|
TMR (1 time)
VF (1 time)
|
1981 Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.
|
| 50 |
transthyretin amyloidosis
(2 times)
|
Nephrology
(1 time)
|
AA (1 time)
FMF (1 time)
SAA (1 time)
|
2003 From renal amyloid deposits to the identification of the culprit genes.
|
| 51 |
transthyretin precursor
(2 times)
|
Biochemistry
(1 time)
|
6-PDGH (1 time)
AAT (1 time)
Apo J (1 time)
|
2008 Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.
|
| 52 |
transthyretin protein
(2 times)
|
Computational Biology
(1 time)
|
FAP (2 times)
BEI (1 time)
CBS (1 time)
|
2011 Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
|
| 53 |
transthyretin-bound
(2 times)
|
Chemistry Techniques, Analytical
(1 time)
|
RBP (2 times)
holo (1 time)
|
1990 Use of free and transthyretin-bound retinol-binding protein in serum as tests of vitamin A status in humans: effect of high creatinine concentrations in serum.
|
| 54 |
transverse transmission/reflection
(2 times)
|
Ophthalmology
(2 times)
|
ARROW (1 time)
MIM (1 time)
|
2009 Attenuation and mode profile determination of leaky/lossy modes in multilayer planar waveguides by a coupling simulation method.
|
| 55 |
treatment required
(2 times)
|
Gastroenterology
(1 time)
|
CS (1 time)
FL (1 time)
LTB (1 time)
|
2016 The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
|
| 56 |
triceps tendon ruptures
(2 times)
|
Orthopedics
(1 time)
|
DKS (1 time)
|
2015 Functional outcomes and complications after surgical repair of triceps tendon rupture.
|
| 57 |
Tumour Tissue Repository
(2 times)
|
Preservation, Biological
(2 times)
|
BC (1 time)
GI (1 time)
PTC (1 time)
|
2013 Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency.
|
| 58 |
fat-to-total fat ratio
(1 time)
|
Endocrine System Diseases
(1 time)
|
BMI (1 time)
LATR (1 time)
LM (1 time)
|
2016 Relationship of lean mass and obesity in Indian urban children and adolescents.
|
| 59 |
H2-treatment temperature
(1 time)
|
Biophysics
(1 time)
|
---
|
2018 On the origin of high-temperature phenomena in Pt/Al2O3.
|
| 60 |
Met30-transthyretin
(1 time)
|
Genetics, Medical
(1 time)
|
FAP (1 time)
|
1998 A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.
|
| 61 |
mRNA--transthyretin
(1 time)
|
Biology
(1 time)
|
AAT (1 time)
AFP (1 time)
ALB (1 time)
|
2006 In vitro differentiation of mouse ES cells into hepatocytes with coagulation factors VIII and IX expression profiles.
|
| 62 |
N-terminal region of transthyretin
(1 time)
|
Biochemistry
(1 time)
|
RBP (1 time)
THs (1 time)
|
2011 Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding protein.
|
| 63 |
re-treatment
(1 time)
|
Hematology
(1 time)
|
CLL (1 time)
CR (1 time)
FC (1 time)
|
2011 Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
|
| 64 |
T-tube repair
(1 time)
|
Diagnostic Imaging
(1 time)
|
BDIs (1 time)
CJ (1 time)
ERC (1 time)
|
2008 Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years.
|
| 65 |
table-top autorefractor
(1 time)
|
Eye Diseases
(1 time)
|
CV (1 time)
Rmax (1 time)
SEV (1 time)
|
2014 Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy.
|
| 66 |
tafamidis to ameliorate transthyretin
(1 time)
|
Biochemistry
(1 time)
|
---
|
2015 Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
|
| 67 |
tafamidis treatment on transthyretin
(1 time)
|
Neurology
(1 time)
|
AEs (1 time)
mBMI (1 time)
NIS-LL (1 time)
|
2016 Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
|
| 68 |
tailored telescopic reconstruction
(1 time)
|
Gastroenterology
(1 time)
|
cDDRs (1 time)
DDR (1 time)
LDLT (1 time)
|
2010 Tailored telescopic reconstruction of the bile duct in living donor liver transplantation.
|
| 69 |
Talent Thoracic Retrospective Registry
(1 time)
|
Cardiology
(1 time)
|
---
|
2009 Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry).
|
| 70 |
tandem tetranucleotide repeat
(1 time)
|
Genetics
(1 time)
|
CF (1 time)
CFTR (1 time)
|
2002 [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].
|
| 71 |
Tangtong Recipe
(1 time)
|
Complementary Therapies
(1 time)
|
VSMCs (1 time)
|
2009 [Effect of tangtong recipe on the proliferation of cultured iliac arterial smooth muscle cells of diabetic rats in vitro].
|
| 72 |
target INR
(1 time)
|
Pharmacology
(1 time)
|
AF (1 time)
GP (1 time)
INR (1 time)
|
2016 Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management.
|
| 73 |
target INR range
(1 time)
|
Pharmacy
(1 time)
|
INR (1 time)
PEFS (1 time)
TER (1 time)
|
2020 Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial.
|
| 74 |
target international normalised ratio range
(1 time)
|
Medicine
(1 time)
|
AF (1 time)
VKAs (1 time)
VTE (1 time)
|
2014 Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.
|
| 75 |
target transthyretin gene
(1 time)
|
Drug Therapy
(1 time)
|
ATTR (1 time)
EMA (1 time)
FDA (1 time)
|
2019 Patisiran for the treatment of patients with familial amyloid polyneuropathy.
|
| 76 |
target tumour response
(1 time)
|
Radiology
(1 time)
|
GIST (1 time)
|
2005 Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.
|
| 77 |
targeted therapy resistance
(1 time)
|
Neoplasms
(1 time)
|
CSCs (1 time)
TT (1 time)
|
2017 At the crossroads of cancer stem cells and targeted therapy resistance.
|
| 78 |
tarsal tunnel release
(1 time)
|
General Surgery
(1 time)
|
PNR (1 time)
SFI (1 time)
SSEP (1 time)
|
2007 Effect of early nerve release on the progression of neuropathy in diabetic rats.
|
| 79 |
taurultame-taurinamide ratio
(1 time)
|
Pharmacology
(1 time)
|
HPLC (1 time)
|
2007 Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
|
| 80 |
taxa-time relationship
(1 time)
|
Medicine
(1 time)
|
CCA (1 time)
DO (1 time)
|
2014 Bacterial community dynamics and taxa-time relationships within two activated sludge bioreactors.
|
| 81 |
TBPA then was renamed transthyretin
(1 time)
|
Chemistry, Clinical
(1 time)
|
RBP (1 time)
TBPA (1 time)
|
2002 Transthyretin from discovery to now.
|
| 82 |
tectoridin
(1 time)
|
Drug Therapy
(1 time)
|
JSRVs (1 time)
RyR (1 time)
|
2000 Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
|
| 83 |
Tectorigenin
(1 time)
|
Complementary Therapies
(1 time)
|
MRSA (1 time)
PGN (1 time)
TEM (1 time)
|
2014 The Antibacterial Assay of Tectorigenin with Detergents or ATPase Inhibitors against Methicillin-Resistant Staphylococcus aureus.
|
| 84 |
temperature rise
(1 time)
|
Anthropology
(1 time)
|
BD (1 time)
CIVD (1 time)
JP (1 time)
|
2016 Cold-induced vasodilation comparison between Bangladeshi and Japanese natives.
|
| 85 |
temperature transition range
(1 time)
|
Dentistry
(1 time)
|
---
|
1979 55 Nitinol wire: force developed as a function of "elastic memory".
|
| 86 |
tendon ruptures
(1 time)
|
Orthopedics
(1 time)
|
QTR (1 time)
|
2018 Simultaneous Ipsilateral Quadriceps and Triceps Tendon Rupture in a Patient with End-Stage Renal Failure.
|
| 87 |
tendon tap response
(1 time)
|
Physical Medicine
(1 time)
|
DTR (1 time)
|
2013 Position-dependent, hyperexcitable patellar reflex dynamics in chronic stroke.
|
| 88 |
tension to rupture
(1 time)
|
Nutritional Sciences
(1 time)
|
DXR (1 time)
ECG (1 time)
TSNIIA-SS (1 time)
|
2009 Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo.
|
| 89 |
test for significance performed on log
(1 time)
|
Endocrinology
(1 time)
|
CBG (1 time)
|
2017 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
|
| 90 |
test their effect on transthyretin
(1 time)
|
Biochemistry
(1 time)
|
EGCG (1 time)
FAP (1 time)
GI (1 time)
|
2012 Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy.
|
| 91 |
testosterone
(1 time)
|
Chemistry
(1 time)
|
17-HPT (1 time)
17beta-HSD (1 time)
ADD (1 time)
|
2011 Modulation of estrogen synthesis through activation of protein kinase A in H295R cells by extracts of estuary sediments.
|
| 92 |
testosterone rebound
(1 time)
|
Neoplasms
(1 time)
|
ADT (1 time)
aHR (1 time)
CVM (1 time)
|
2018 Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.
|
| 93 |
testosterone recovery
(1 time)
|
Neoplasms
(1 time)
|
HT (1 time)
PCa (1 time)
RT (1 time)
|
2009 Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
|
| 94 |
tetraene ratio
(1 time)
|
Nutritional Sciences
(1 time)
|
EFAD (1 time)
HTPN (1 time)
|
1996 Essential fatty acid deficiency and home total parenteral nutrition patients.
|
| 95 |
tetranucleotide tandem repeat
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2002 [Tetranucleotide tandem repeat polymorphism of the CFTR gene intron 6B in populations of the Volga-Ural region].
|
| 96 |
tetrathionate-reductase activity
(1 time)
|
Tropical Medicine
(1 time)
|
---
|
1981 [Salmonella typhi lysotypes in Iraq (1974-1979)].
|
| 97 |
Thai Twin Registry
(1 time)
|
Genetics, Medical
(1 time)
|
DZ (1 time)
FP (1 time)
MZ (1 time)
|
2013 Thai Twin Registry: description of the initial stage.
|
| 98 |
than those with transthyretin
(1 time)
|
Cardiology
(1 time)
|
---
|
2014 Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
|
| 99 |
than Transthyretin
(1 time)
|
Biochemistry
(1 time)
|
FAP (1 time)
|
2012 Genotype--phenotype correlation in FAP.
|
| 100 |
them, the expression of transthyretin
(1 time)
|
Neoplasms
(1 time)
|
AAT (1 time)
CLU (1 time)
CRPC (1 time)
|
2012 Changes of transthyretin and clusterin after androgen ablation therapy and correlation with prostate cancer malignancy.
|
A Search Service for Abbreviation / Long Form